A review of intensity-modulated radiation therapy

Current Oncology Reports

Volumn 10, Issue 4, 2008, Pages 294-299

  Gaspar, Laurie E ^a   Ding, Meisong ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; PLEURA MESOTHELIOMA; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING; LUNG TUMOR; METHODOLOGY; RADIOGRAPHY; SCINTISCANNING;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 56149087269     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-008-0046-3     Document Type: Review

References (35)

1. Galvin JM, Ezzell G, Eisbrauch A, et al.: Implementing IMRT in clinical practice: A joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 2004, 58:1616-1634.
2. Purdy J: Current ICRU definitioLs of volumes: limitations and future directions. Semin Radiat Oncol 2004, 14:27-40.
3. Mell LK, Mehrotra AK, Mundt AJ: Intensity-modulated radiation therapy use in the US, 2004. Cancer 2005, 104:1296-1303.
4. Palta JR, Deye JA, Ibbott GS, et al.: Credentialing of institutions for IMRT in clinical trials. Int J Radiat Oncol Biol Phys 2004, 59:1257-1259.
5. Chen QS, Weinhous MS, Deibel FC, et al.: Fluoroscopic study of tumor motion due to breathing: Facilitating precise radiation therapy for lung cancer patients. Med Phys 2001, 28:850-1856.
6. Stevens CW, Munden RF Forster KM, et al.: Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. Int J Radiat Oncol Biol Phys 2001, 51:62-68.
7. Jiang SB, Pope C, Jarrah KM, et al.: An experimental investigation on intra-fractional organ motion effects in lung IMRT treatment. Phys Med Biol 2003, 48:1773-1784.
8. Chui CS, Yorke E, Hong L: The effects of intra-fraction organ motion on the delivery of intensity-modulated field with a multileaf collimator. Med Phys 2003, 30:1736-1746.
9. Li XA, Stepaniak C, Gore E: Technical and dosimetric aspects of respiratory gating using a pressure-sensor motion monitoring system. Med Phys 2006, 33:145-154.
10. Liu HH, Balter P, Tutt T, et al.: Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 2007, 68:531-540.
11. Britton KR, Starkschall G, Tucker SL, et al.: Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 2007, 68:1036-1046.
12. LagerwaIrd FJ, Senan S: Lung cancer: intensity-modulated radiation therapy, four-dimensional imaging and mobility management. Front Radiat Ther Oncol 2007, 40:239-252.
13. Pan T, Lee TY, Rietzel E, et al.: 4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT. Med Phys 2004, 31:333-340.
14. Keall PJ, Starkschall G, Shukla H, et al.: Acquiring 4D thoracic CT scans using a multislice helical method. Phys Med Biol 2004, 49:2053-2067.
15. Advanced Technology Consortium: ATC Guidelines for the Use of IMRT (including Intra-Thoracic Treatments). Available at http://www3.cancer.gov/rrp/imrt.doc. Accessed April 28, 2008.
16. Murshed H, Liu HH, Liao Z, et al.: Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 58:1258-1267.
17. Grills IS, Yan D, Martinez AA, et al.: Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 2003, 57:875-890.
18. Allen AM, Czerminska M, Janne PA, et al.: Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006, 65:640-645.
19. Rice DC, Smythe WR, Liao Z, et al.: Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2007, 69:350-357.
20. Brenner DJ, Hall EJ: Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007, 357:2277-2284.
21. Song Y, Chan M, Burman C, Cann D: Inter-modality variation in gross tumor volume delineation in 18FDG-PET guided IMRT treatment planning for lung cancer. Proceedings of the 28th IEEE EMBS Annual International Conference. August 30-September 3, 2006; New York, NY.
22. Bradley J, Thorstad WL, Mutic S, et al.: Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 59:78-86.
23. Lavrenkov K, Christian JA, Partridge M, et al.: A potential to reduce pulmonary toxicity: The use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol 2007, 83:156-162.
24. Shioyama Y, Jang SY, Liu HH, et al.: Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 68:1349-1358.
25. Wang S, Liao Z, Wei X, et al.: Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006, 66:130-137.
26. Christian JA, Bedford JL, Webb S, et al.: Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 67:735-741.
27. Schwarz M, Alber M, Lebesque JV, et al.: Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005, 62:561-570.
28. Yom SS, Liao Z, Liu HH, et al.: Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007, 68:94-102.
29. Jensen AD, Münter MW, Bischoff H, et al.: Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: The NEAR protocol (NCT00115518). BMC Cancer 2006, 6:122.
30. Radiation Therapy Oncology Group (RTOG 0617): A randomized phase III comparison of standard dose (60Gy) versus high-dose (74Gy) conformal radiotherapy with concurrent and consolidation carboplatin/paclitaxel in patients with stage IIIA/IIIB non-small cell lung cancer. Available at: http://www.rtog.org/members/protocols/0617/0617.pdf. Accessed April 28, 2008.
31. Holloway CL, Robinson D, Murray B, et al.: Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 2004, 73:285-287.
32. Krayenbuehl J, Oertel S, Davis JB, et al.: Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy. Int J Radiat Oncol Biol Phys 2007, 69:1593-1599.
33. Rice DC, Stevens CW, Correa AM, et al.: Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007, 84:1685-1692.
34. Allen AM, Schofield D, Hacker F, et al.: Restricted field IMRT dramatically enhances IMRT planning for mesothelioma. Int J Radiat Oncol Biol Phys 2007, 69:1587-1592.
35. Scherpereel A: Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma. Respir Med 2007, 101:1265-1276.